Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Comment by bligickaon Oct 31, 2020 7:32am
278 Views
Post# 31818143

RE:Hey Blig, question

RE:Hey Blig, questionFirst off at this point l would publish the data, don't know why they are keeping it secret it's already protected by patent....if the results from the experiments are that good then share them it will generate government funding and obviously we need to move to phase 1 before the competition eats our lunch !!! Competition already is locking down presales of their vaccines getting huge deposits......Vaxil needs to move on with their phase 1-3 while teaming up with a manufacturing capable partner in order to take in deposits for it's vaccine.
bigbanktheory wrote: If you were running the show, what would be your next step, now whatever that step is, explain why you think that hasn't happened yet with the company given the last update. Your comments are quite interesting. Ty. Glta


<< Previous
Bullboard Posts
Next >>